SlideShare a Scribd company logo
1 of 2
Download to read offline
Scale Up & cGMP Manufacturing
You have taken your drug candidate as far as you can. It
is time to scale up your process from the bench to clinical
or commercial size batches. But is your process robust
enough? Will it stand up to a 5,10, 50 or100 times scale up?
Who can you turn to for protein and antibody scale up and
cGMP manufacturing experience? Therapure is your trusted
partner who can meet your process scale up and cGMP
manufacturing needs.
Therapure Biopharma operates a 130,000 ft2 world-class
facility with over 28,000 ft2 of cGMP manufacturing space.
Operating a range of classified suites from Grade A
(Class 100:ISO 5) through Grade C (Class 100,000:ISO 8),
Therapure maintains utilities compliant to USP and EP
including Water for Injection, Purified Water, Clean Steam
and Oil-Free Compressed Air.
During process scale up, Therapure keeps its clients
engaged in the project, actively soliciting decisions on
raw materials, components, consumables, process
specific Standard Operating Procedures (SOPs), Batch
Production Records, Analytical Test Methods, Product
Specifications and Process Flow Diagrams. We work as
an extension of your organization, adding value as your
trusted manufacturing partner. When batch manufacturing
starts, we encourage clients to be onsite, observing the
manufacturing runs with us. Upon completion, we review
the run with the client, going through every technical aspect
of the batch records in order to fine tune the process for
the next run.
Therapure has experience utilizing a variety
of different sources of API including:
n Whole Blood and Plasma
n Mammalian Cell Culture
n Primary Cell Culture
Scale Up  cGMP Manufacturing
Highlights of our manufacturing capabilities and capacities:
Tissue Processing
n Dedicated Grade C (Class 100,000:ISO 8)
suites through configurable HVAC systems
Protein Manufacturing
Upstream
n Mammalian cell culture processes (CHO,
HEK-293, Hybridoma, etc.)
n Microbial processes (through strategic partnerships)
n Master Cell Bank (MCB) creation
n Seed train from 5L to 500L Single Use Bioreactors
(SUBs)
n Media preparation up to 6,000L batches
Midstream
n Harvest by nominal flow filtration, tangential flow
filtration or centrifugation
n Viral inactivation tanks (pH, solvent-detergent,
temperature)
n Nanofiltration
Downstream
n Dedicated ‘non-live’ processing area
n Chromatographic volumetric rates from 10mL/min
to 10L/min
n Ultrafiltration / diafiltration up to 100 m2 of membrane
n Protein modification (conjugation, refolding,
enzymatic conversion, etc.)
n Buffer preparation up to 6,000L batches
n Bulk filling Therapure Biopharma Inc.
2585 Meadowpine Boulevard,
Mississauga, Ontario Canada L5N 8H9
Telephone:	 +1 905 286 6200
Fax:	 +1 905 286 6300
www.therapurebio.com
your trusted partner
for contract protein development  manufacturing

More Related Content

What's hot

How to reach High Plasma Protein Concentration with Single-Pass TFF
How to reach High Plasma Protein Concentration with Single-Pass TFFHow to reach High Plasma Protein Concentration with Single-Pass TFF
How to reach High Plasma Protein Concentration with Single-Pass TFFMerck Life Sciences
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up MilliporeSigma
 
Addressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral VectorsAddressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral VectorsMilliporeSigma
 
Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...MilliporeSigma
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmMilliporeSigma
 
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadMerck Life Sciences
 
BBI Solutions - Contract Services
BBI Solutions - Contract ServicesBBI Solutions - Contract Services
BBI Solutions - Contract ServicesBBISolutions
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)XiaomingJerryYang
 
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...MilliporeSigma
 
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...MilliporeSigma
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...KBI Biopharma
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...MilliporeSigma
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyMerck Life Sciences
 
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...MilliporeSigma
 
Dilip Shah_Resume
Dilip Shah_ResumeDilip Shah_Resume
Dilip Shah_ResumeDilip Shah
 
Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Merck Life Sciences
 

What's hot (19)

How to reach High Plasma Protein Concentration with Single-Pass TFF
How to reach High Plasma Protein Concentration with Single-Pass TFFHow to reach High Plasma Protein Concentration with Single-Pass TFF
How to reach High Plasma Protein Concentration with Single-Pass TFF
 
Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up	Complete single-use ADC technology from development through scale-up
Complete single-use ADC technology from development through scale-up
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Addressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral VectorsAddressing the Challenge of Scalability in Viral Vectors
Addressing the Challenge of Scalability in Viral Vectors
 
Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...Process development guidance for AAV and lentivirus manufacturing based on co...
Process development guidance for AAV and lentivirus manufacturing based on co...
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
 
BBI Solutions - Contract Services
BBI Solutions - Contract ServicesBBI Solutions - Contract Services
BBI Solutions - Contract Services
 
HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)HJB CDMO Introduction (2019)
HJB CDMO Introduction (2019)
 
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
 
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
Key to Successful Formulation Development for Lipid Based RNA Delivery and Va...
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
Employing Innovative Platform Manufacturing and Biosafety Testing for your Ge...
 
Dilip Shah_Resume
Dilip Shah_ResumeDilip Shah_Resume
Dilip Shah_Resume
 
Resume-Mon Anly Villaflor
Resume-Mon Anly VillaflorResume-Mon Anly Villaflor
Resume-Mon Anly Villaflor
 
Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...
 
Mycenax Introduction_
Mycenax Introduction_Mycenax Introduction_
Mycenax Introduction_
 

Similar to Scale up and c gmp manufacturing

Inogent - Excellence Through Innovation
Inogent - Excellence Through Innovation Inogent - Excellence Through Innovation
Inogent - Excellence Through Innovation gvk_bio
 
Highly accelerated platforms for mAb and next generation mAb manufacturing
Highly accelerated platforms for mAb and next generation mAb manufacturingHighly accelerated platforms for mAb and next generation mAb manufacturing
Highly accelerated platforms for mAb and next generation mAb manufacturingKBI Biopharma
 
Presentation Of Capabilities Elf
Presentation Of Capabilities   ElfPresentation Of Capabilities   Elf
Presentation Of Capabilities ElfEmma Lee
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization KBI Biopharma
 
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdfYaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdfJasonSoung
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyMilliporeSigma
 
Bram cor-turnkey-05-2012-en-web
Bram cor-turnkey-05-2012-en-webBram cor-turnkey-05-2012-en-web
Bram cor-turnkey-05-2012-en-webgaominh
 
Kemwell Analytical presentation
Kemwell Analytical presentation Kemwell Analytical presentation
Kemwell Analytical presentation MithaliRosario
 
JeffWright_Resume_2015
JeffWright_Resume_2015JeffWright_Resume_2015
JeffWright_Resume_2015Jeffrey Wright
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy
 
Sartorius Cell Line Development
Sartorius Cell Line Development Sartorius Cell Line Development
Sartorius Cell Line Development Raymond Goyco, III
 
Honeywell User's Group Almirall's MES case study
Honeywell User's Group Almirall's MES case studyHoneywell User's Group Almirall's MES case study
Honeywell User's Group Almirall's MES case studyDavid Badia
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Aniket Manathkar
 
New company profile(august 2010)
New company profile(august 2010)New company profile(august 2010)
New company profile(august 2010)Seperations
 

Similar to Scale up and c gmp manufacturing (20)

Inogent - Excellence Through Innovation
Inogent - Excellence Through Innovation Inogent - Excellence Through Innovation
Inogent - Excellence Through Innovation
 
Highly accelerated platforms for mAb and next generation mAb manufacturing
Highly accelerated platforms for mAb and next generation mAb manufacturingHighly accelerated platforms for mAb and next generation mAb manufacturing
Highly accelerated platforms for mAb and next generation mAb manufacturing
 
Presentation Of Capabilities Elf
Presentation Of Capabilities   ElfPresentation Of Capabilities   Elf
Presentation Of Capabilities Elf
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
My Industrial Training
My  Industrial Training My  Industrial Training
My Industrial Training
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdfYaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
 
Chromcol Catalog
Chromcol CatalogChromcol Catalog
Chromcol Catalog
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Bram cor-turnkey-05-2012-en-web
Bram cor-turnkey-05-2012-en-webBram cor-turnkey-05-2012-en-web
Bram cor-turnkey-05-2012-en-web
 
Royal Link Pharma
Royal Link PharmaRoyal Link Pharma
Royal Link Pharma
 
Kemwell Analytical presentation
Kemwell Analytical presentation Kemwell Analytical presentation
Kemwell Analytical presentation
 
JeffWright_Resume_2015
JeffWright_Resume_2015JeffWright_Resume_2015
JeffWright_Resume_2015
 
BioDuro
BioDuro BioDuro
BioDuro
 
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-BiopharmaceuticalsMedipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
Medipolis GMP Oy Presentation -Dr. Ashesh Kumar Director-Biopharmaceuticals
 
Sartorius Cell Line Development
Sartorius Cell Line Development Sartorius Cell Line Development
Sartorius Cell Line Development
 
validation.pdf
validation.pdfvalidation.pdf
validation.pdf
 
Honeywell User's Group Almirall's MES case study
Honeywell User's Group Almirall's MES case studyHoneywell User's Group Almirall's MES case study
Honeywell User's Group Almirall's MES case study
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016
 
New company profile(august 2010)
New company profile(august 2010)New company profile(august 2010)
New company profile(august 2010)
 

Recently uploaded

Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationRadu Cotescu
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking MenDelhi Call girls
 
Maximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxMaximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxOnBoard
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024BookNet Canada
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesSinan KOZAK
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonetsnaman860154
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking MenDelhi Call girls
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptxHampshireHUG
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhisoniya singh
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)Gabriella Davis
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slidespraypatel2
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdfhans926745
 

Recently uploaded (20)

Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 
Maximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxMaximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptx
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen Frames
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonets
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping Elbows
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slides
 
[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf[2024]Digital Global Overview Report 2024 Meltwater.pdf
[2024]Digital Global Overview Report 2024 Meltwater.pdf
 

Scale up and c gmp manufacturing

  • 1. Scale Up & cGMP Manufacturing You have taken your drug candidate as far as you can. It is time to scale up your process from the bench to clinical or commercial size batches. But is your process robust enough? Will it stand up to a 5,10, 50 or100 times scale up? Who can you turn to for protein and antibody scale up and cGMP manufacturing experience? Therapure is your trusted partner who can meet your process scale up and cGMP manufacturing needs. Therapure Biopharma operates a 130,000 ft2 world-class facility with over 28,000 ft2 of cGMP manufacturing space. Operating a range of classified suites from Grade A (Class 100:ISO 5) through Grade C (Class 100,000:ISO 8), Therapure maintains utilities compliant to USP and EP including Water for Injection, Purified Water, Clean Steam and Oil-Free Compressed Air. During process scale up, Therapure keeps its clients engaged in the project, actively soliciting decisions on raw materials, components, consumables, process specific Standard Operating Procedures (SOPs), Batch Production Records, Analytical Test Methods, Product Specifications and Process Flow Diagrams. We work as an extension of your organization, adding value as your trusted manufacturing partner. When batch manufacturing starts, we encourage clients to be onsite, observing the manufacturing runs with us. Upon completion, we review the run with the client, going through every technical aspect of the batch records in order to fine tune the process for the next run. Therapure has experience utilizing a variety of different sources of API including: n Whole Blood and Plasma n Mammalian Cell Culture n Primary Cell Culture Scale Up cGMP Manufacturing
  • 2. Highlights of our manufacturing capabilities and capacities: Tissue Processing n Dedicated Grade C (Class 100,000:ISO 8) suites through configurable HVAC systems Protein Manufacturing Upstream n Mammalian cell culture processes (CHO, HEK-293, Hybridoma, etc.) n Microbial processes (through strategic partnerships) n Master Cell Bank (MCB) creation n Seed train from 5L to 500L Single Use Bioreactors (SUBs) n Media preparation up to 6,000L batches Midstream n Harvest by nominal flow filtration, tangential flow filtration or centrifugation n Viral inactivation tanks (pH, solvent-detergent, temperature) n Nanofiltration Downstream n Dedicated ‘non-live’ processing area n Chromatographic volumetric rates from 10mL/min to 10L/min n Ultrafiltration / diafiltration up to 100 m2 of membrane n Protein modification (conjugation, refolding, enzymatic conversion, etc.) n Buffer preparation up to 6,000L batches n Bulk filling Therapure Biopharma Inc. 2585 Meadowpine Boulevard, Mississauga, Ontario Canada L5N 8H9 Telephone: +1 905 286 6200 Fax: +1 905 286 6300 www.therapurebio.com your trusted partner for contract protein development manufacturing